Otonomy, Inc. OTIC Balance Sheet

Otonomy, inc. (OTIC)

Balance Sheet / TTM

Mar'20	Dec'19	Sep'19	Jun'19	Mar'19	Dec'18	Sep'18	Jun'18	Mar'18	Dec'17	Sep'17	Jun'17	Mar'17	Dec'16	Sep'16	Jun'16	Mar'16	Dec'15	Sep'15	Jun'15	Mar'15	Dec'14	Sep'14	Dec'13
Assets
Current assets:
Cash and cash equivalents
31,038	25,194	16,257	12,142	16,276	33,633	21,382	19,024	23,217	18,456	16,877	22,332	13,704	24,156	19,760	46,569	244,285	158,664	176,602	190,294	201,042	139,810	-	37,284
Short-term investments
17,568	35,476	51,897	66,309	70,671	63,651	71,180	80,984	87,007	101,548	117,431	128,200	154,420	172,222	195,504	192,451	21,730	26,172	22,587	21,598	22,560	16,223	-	-
Accounts receivable, net
-	-	33	68	14	108	45	14	133	107	126	76	178	91	87	2	146	0	-	-	-	-	-	-
Inventory
-	-	-	-	-	-	-	-	0	-	1,238	1,191	1,201	1,435	1,741	913	614	0	-	-	-	-	-	-
Cash
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	165,155	-
Restricted cash
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	75
Short-term investments
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0
Prepaid and other current assets
2,199	2,480	3,683	1,497	2,093	2,677	2,413	2,398	2,357	2,334	3,825	3,538	4,088	4,316	5,652	5,647	3,960	3,319	5,260	4,159	4,337	1,669	2,177	1,654
Total current assets
50,805	63,150	71,870	80,016	89,054	100,069	95,020	102,420	112,714	122,445	139,497	155,337	173,591	202,220	222,744	245,582	270,735	188,155	204,449	216,051	227,939	157,702	167,332	39,013
Restricted cash
702	701	700	699	698	696	695	1,160	1,159	1,158	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Restricted cash
-	-	-	-	-	-	-	-	-	-	1,157	697	697	697	696	696	696	695	695	695	-	0	-	-
Property and equipment, net
3,413	3,702	3,646	3,758	3,883	3,996	4,269	4,529	4,517	4,679	5,267	5,102	5,247	4,977	4,075	3,478	3,211	3,094	2,851	1,727	1,617	1,257	952	683
Right-of-use assets
15,131	15,465	15,792	16,111	16,421	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Other long-term assets
-	-	0	231	231	231	231	82	82	82	82	550	550	702	868	696	820	1,086	489	692	460	205	41	61
Total assets
70,051	83,018	92,008	100,815	110,287	104,992	100,215	108,191	118,472	128,364	146,003	161,686	180,085	208,596	228,383	250,452	275,462	193,030	208,484	219,165	230,016	159,164	168,325	39,757
Liabilities and Stockholders’ Equity
Current liabilities:
Accounts payable
897	1,161	959	1,873	1,152	1,029	1,294	877	2,517	961	1,739	1,303	212	1,292	934	800	2,377	3,450	2,094	4	1,928	1,710	1,748	2,014
Accrued expenses
4,512	5,442	4,505	4,060	4,177	3,788	3,566	2,645	2,612	3,881	4,807	4,831	6,254	9,064	6,794	5,628	4,581	4,551	4,196	4,730	3,708	3,046	2,486	384
Accrued compensation
1,429	2,593	2,044	1,732	1,243	2,635	2,341	1,943	1,776	3,307	4,125	3,338	2,886	4,839	4,886	4,110	2,773	3,189	2,316	1,468	1,162	575	1,254	244
Long-term debt, current
1,286	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Leases, current
3,308	3,302	3,290	3,267	3,245	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Deferred product sales, net
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	79	129	-	-	-	-	-	-	-
Deferred rent, current
-	-	0	0	0	38	37	39	41	42	43	38	38	38	59	85	111	101	97	94	90	86	83	73
Total current liabilities
11,432	12,498	10,798	10,932	9,817	7,490	7,238	5,504	6,946	8,191	10,714	9,510	9,390	15,233	12,673	10,702	9,971	11,291	8,703	6,296	6,888	5,417	5,571	2,715
Long-term debt, net of current
13,731	14,967	14,917	14,869	14,822	14,764	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Leases, net of current
14,951	15,320	15,673	16,020	16,359	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Convertible preferred stock warrant liability
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	646
Deferred rent, net of current
-	-	0	0	0	3,001	2,979	2,951	2,922	2,894	2,851	2,114	1,370	626	371	305	239	205	164	122	111	134	156	220
Total liabilities
40,114	42,785	41,388	41,821	40,998	25,255	10,217	8,455	9,868	11,085	13,565	11,624	10,760	15,859	13,044	11,007	10,210	11,496	8,867	6,418	6,999	5,551	5,727	3,581
Commitments and Contingencies
0	0	0	0	0	-	0	0	0	-	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Convertible preferred stock
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-
Stockholders’ equity:
Preferred stock, $0.001 par value; 10,000,000 shares authorized at March 31, 2020 and December 31, 2019; no shares issued or outstanding at March 31, 2020 and December 31, 2019
0	0	0	0	0	-	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Common stock, $0.001 par value; 200,000,000 shares authorized at March 31, 2020 and December 31, 2019; 30,814,211 shares issued and outstanding at March 31, 2020 and December 31, 2019
31	31	31	31	31	31	31	31	31	31	30	30	30	30	30	30	30	24	24	24	24	21	21	0
Additional paid-in capital
501,498	500,084	499,512	497,819	496,443	494,947	492,388	489,578	484,943	482,198	478,485	475,170	471,203	467,468	463,418	459,939	456,122	345,647	342,588	339,753	337,479	256,061	255,252	580
Accumulated other comprehensive income
64	11	45	73	17	-23	-48	-46	-96	-100	-60	-119	-110	-41	39	52	-	0	-	-	-	-	-	-
Accumulated deficit
-471,656	-459,893	-448,968	-438,929	-427,202	-415,218	-402,373	-389,827	-376,274	-364,850	-346,017	-325,019	-301,798	-274,720	-248,148	-220,576	-190,900	-164,137	-142,995	-127,030	-114,486	-102,469	-92,675	-59,557
Total stockholders’ equity
29,937	40,233	50,620	58,994	69,289	79,737	89,998	99,736	108,604	117,279	132,438	150,062	169,325	192,737	215,339	239,445	265,252	181,534	199,617	212,747	223,017	153,613	162,598	-58,977
Total liabilities and stockholders’ equity
70,051	83,018	92,008	100,815	110,287	104,992	100,215	108,191	118,472	128,364	146,003	161,686	180,085	208,596	228,383	250,452	275,462	193,030	208,484	219,165	230,016	159,164	168,325	39,757